帮助 本站公告
您现在所在的位置:网站首页 > 知识中心 > 文献详情
文献详细Journal detailed

分化型甲状腺癌肺转移^131I治疗后早期Tg变化与远期临床转归的关系
Relationship between the initial change of Tg and outcome in differentiated thyroid carcinoma patients with pulmonary metastases after ^131I treatment

作  者: (王宸); (赵腾); (李娇); (高文); (林岩松);

机构地区: 中国医学科学院、北京协和医学院北京协和医院核医学科,100730

出  处: 《中华核医学与分子影像杂志》 2017年第9期555-558,共4页

摘  要: 目的探讨DTC肺转移患者^131I治疗后早期Tg变化与远期临床转归的关系。方法回顾性分析2008年1月至2014年6月合并肺转移DTC患者47例[男13例,女34例;平均年龄(41.6±16.3)岁], 根据2次^131I治疗后血清抑制性Tg变化分为3组:G1组,Tg呈下降趋势,且下降幅度大于50%;G2组,Tg下降幅度不足50%或上升幅度不足10%;G3组,Tg水平上升,且升高幅度大于10%。中位随访时间为1 501 d,根据血清学及影像学随诊结果将患者临床转归分为缓解、稳定、进展。探讨^131I治疗后早期Tg变化与远期临床转归间的关系。采用χ^2检验、Fisher确切概率法分析数据。结果G1组占44.7%(21/47),G2组占40.4%(19/47),G3组占14.9%(7/47)。G1组缓解人数占19.0%(4/21)、稳定占81.0%(17/21)、无进展患者,G2组相应数据为2/19、12/19和5/19,G3组全部进展(7/7)。^131I治疗后早期Tg变化与远期临床转归有关(Fisher确切概率法,P〈0.01)。 结论早期^131I治疗后的抑制性Tg水平变化有助于预测DTC肺转移患者的远期临床转归。^131I治疗后的抑制性Tg水平上升者,提示从^131I治疗中获益小,进展为^131I难治性概率加大。 Objective To investigate the relationship between the initial change of Tg and clinical outcome in DTC patients with pulmonary metastases after ^131I treatment. Methods A total of 47 DTC patients (13 males, 34 females; average age (41.6±16.3) years) with pulmonary metastases from January 2008 to June 2014 were retrospectively analyzed. Patients were divided into 3 groups according to the variation of Tg: G1 with a declined (more than 50%) Tg; G2 with a declined (less than 50%) Tg or an increased (less than 10%) Tg; G3 with an increased (more than 10%) Tg. The median follow-up time was 1 501 d. Clinical outcomes were divided into remission, stable disease and progressive disease according to the serum test and imaging results. Data analysis was performed by Х^2 test and Fisher exact test. Results The percent- age of G1, G2, G3 patients was 44.7% (21/47) , 40.4% (19/47) , and 14.9% (7/47) respectively. Results of follow-up showed 19.0%(4/21 ) patients achieved remission and 81.0% (17/21) with stable disease in G1. There were 2/19 with remission, 12/19 with stable disease and 5/19 with progression disease in G2. All patients (7/7) had progressive disease in G3. The clinical outcome was related to the variation of Tg after ^131I treatment (Fisher exact test, P〈0.01). Conclusions Initial Tg after ^131I treatment could be a predictor to the outcome of patients. The increased Tg level indicates a high possibility of ^131I refractory disease.

关 键 词: 甲状腺肿瘤 肿瘤转移 放射疗法 碘放射性同位素 治疗结果 甲状腺球蛋白

相关作者

作者 许健上

相关机构对象

机构 中山大学岭南学院
机构 广东外语外贸大学南国商学院

相关领域作者

作者 庞菊香
作者 康秋实
作者 康超
作者 廖伟导
作者 廖刚